Trial Profile
Phase 1, Non-Randomized, Parallel-Group, Open-Label Study to Characterize the Pharmacokinetics of a Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment Compared to Healthy Subjects
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2023
Price :
$35
*
At a glance
- Drugs Bevenopran (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors Cubist Pharmaceuticals
- 29 Jul 2015 New trial record